Injectable immunotherapy shrinks precancerous mouth lesions and spares patients from surgery
Injectable immunotherapy delivered directly into precancerous lesions in the mouth significantly reduced their size and helped the majority of patients avoid surgery, according to results from a phase I clinical trial presented at the American Association for Cancer Research Annual Meeting in April 2026. Roughly 5 percent of the general population carries precancerous lesions in […]